Stephens Upgrades Neogenomics (NEO) to Overweight

Stephens analyst Mason Carrico upgraded Neogenomics (NASDAQ: NEO) from Equal Weight to Overweight with a price target of $18.00 (from $16.00).

For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.

Shares of Neogenomics closed at $13.55 yesterday.

You May Also Be Interested In

• Coinbase (COIN) PT Raised to $212 at Cantor Fitzgerald
• Affirm Holdings (AFRM) PT Raised to $110 at Bernstein SocGen Group
• BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $105 at Jefferies